Daisuke Takei

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hironobu Hashimoto, Masakazu Abé, Osamu Tokuyama et al. · The Lancet Oncology · 2019 · 218 citations

Drug Safety, Chemotherapy-induced Nausea, Pharmacology +7

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test

Shiho Takashima, Jun Kato, Sakiko Hiraoka et al. · The American Journal of Gastroenterology · 2015 · 117 citations

Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohnʼs Disease

Toshihiro Inokuchi, Jun Kato, Sakiko Hiraoka et al. · Inflammatory Bowel Diseases · 2016 · 60 citations · Full text

Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis

Sakiko Hiraoka, Toshihiro Inokuchi, Asuka Nakarai et al. · Gut and Liver · 2017 · 34 citations · Full text

Consecutive Measurements by Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Detect Clinical Relapse

Sakiko Hiraoka, Jun Kato, Asuka Nakarai et al. · Journal of Crohn s and Colitis · 2016 · 32 citations · Full text